Hemocyanin regulates phosphatidylcholine metabolism to enhance reactive oxygen species–mediated immunity in Pacific white shrimp ( Penaeus vannamei )
The Journal of Immunology · 17.03.2026 · 215 (3)
DOI: 10.1093/jimmun/vkag018 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 18.03.2026. Verfasst von Yunyu Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, China. Hauptthemen laut MEDLINE: Penaeidae, Reactive Oxygen Species, Phosphatidylcholines, Hemocyanins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Shantou University Scientific Research Initiation.
Abstract (Originalsprache)
Acute hepatopancreatic necrosis disease (AHPND) is one of the most severe threats to global shrimp aquaculture. Recent studies report a significant reduction in hepatopancreas hemocyanin levels in Penaeus vannamei (PvHMC) by AHPND. To investigate the functional implications, we performed liquid chromatography-tandem mass spectrometry–based metabolomics and found that PvHMC knockdown caused a marked accumulation of phosphatidylcholine (PC). qPCR and ELISA analyses further showed that PvHMC suppression upregulated the mRNA expression, protein abundance, and enzymatic activity of PvCPT1, a key enzyme in PC synthesis. Co-immunoprecipitation and confocal immunofluorescence analyses confirmed a direct interaction between PvHMC and PvCPT1, indicating that PvHMC regulates PC metabolism by binding to PvCPT1. Functional assays demonstrated that exogenous PC supplementation significantly increased reactive oxygen species (ROS) production, whereas simultaneous knockdown of PvHMC and PvCPT1 reduced plasma PC levels and ROS activity. Under pathogenic challenge, PC administration inhibited Vibrio parahaemolyticus (VpAHPND) proliferation by enhancing intracellular ROS-mediated antimicrobial responses, ultimately improving shrimp survival. In summary, PvHMC regulates PC metabolism to modulate ROS levels, strengthening shrimp’s immune defense against pathogenic infections. These findings reveal a novel metabolic regulatory role of PvHMC in response to VpAHPND infection and suggest potential strategies for controlling AHPND in shrimp aquaculture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, China.
- Guangxi Academy of Fishery Sciences, Guangxi Key Laboratory of Aquatic Genetic Breeding and Healthy Aquaculture, Nanning, China.
ORCID-Profile: Xianliang Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Shantou University Scientific Research Initiation
Zitieren
APA
Shi, Y., Kong, Y. H., Bao, S., Zhou, Y., Cheng, J., Zheng, Z., Zhao, Y., Zhao, X., & Zhang, Y. (2026). Hemocyanin regulates phosphatidylcholine metabolism to enhance reactive oxygen species–mediated immunity in Pacific white shrimp ( Penaeus vannamei ). The Journal of Immunology, 215(3). https://doi.org/10.1093/jimmun/vkag018
Vancouver
Shi Y, Kong YH, Bao S, Zhou Y, Cheng J, Zheng Z, et al. Hemocyanin regulates phosphatidylcholine metabolism to enhance reactive oxygen species–mediated immunity in Pacific white shrimp ( Penaeus vannamei ). The Journal of Immunology. 2026;215(3). doi:10.1093/jimmun/vkag018
BibTeX
@article{Shi2026,
author = {Shi, Yunyu and Kong, Yong-Hui and Bao, Shiyuan and Zhou, Yuqing and Cheng, Jiawei and Zheng, Zhihong and Zhao, Yongzhen and Zhao, Xianliang and Zhang, Yueling},
title = {Hemocyanin regulates phosphatidylcholine metabolism to enhance reactive oxygen species–mediated immunity in Pacific white shrimp ( Penaeus vannamei )},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {3},
doi = {10.1093/jimmun/vkag018}
}
EUVIMED